Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Original Article

A. Menzies-Gow, J. Corren, A. Bourdin, G. Chupp, E. Israel, M.E. Wechsler, C.E. Brightling, J.M. Griffiths, Å. Hellqvist, K. Bowen, P. Kaur, G. Almqvist, S. Ponnarambil, and G. Colice

N Engl J Med 2021;384:1800-1809

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
05/12/2021
Course expires: 
05/13/2023

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, May 13, 2023 - 11:59pm.